Q1 2026 neurotech funding hits $976M — 577% higher than Q1 2025, driven by BrainCo and Merge Labs
Summary
Q1 2026 neurotech funding reached $976 million across publicly disclosed rounds, representing a 577% increase over Q1 2025's $144M. The quarter was led by BrainCo's $286M round, Merge Labs' $252M seed, and Science Corporation's continued fundraising. Even excluding the two largest deals, underlying funding trend showed steady growth suggesting broad market momentum beyond headline-grabbing mega-rounds.
Why it matters
Q1 2026's $976M quarterly total — approaching $1 billion — indicates neurotech funding has reached a new structural level rather than being driven solely by one-off outlier investments. Multiple companies raising $50M+ simultaneously suggests the investor consensus has shifted from "experimental technology" to "emerging industry."
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial